Interest of Auriculotherapy in Prophylaxis of Migraine and Headache in Patients With Migraines (Migauric)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Know the risks and potential benefits of clinical studies and talk to your health care provider before participating.
Read our disclaimer for details.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
18 Months to 80 Years (Child, Adult, Senior)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Benefiting from social security scheme or legal successor;
Having given their non-opposition to the study; ·
Diagnosis of chronical migraine for more than 6 months
Without prophylactic treatment or with a prophylactic treatment for more than 1 month
presenting a calendar of migraines and headaches mentioning the number of days with pain, intensity of pain and treatments for at least 3 months.
Non inclusion Criteria:
patients with less than 6 painful episodes in 3 months
history or actual mental health disorder
Dependence on opioids or tranquillizers
Incapacitated to keep a diary of the migraines / headaches / treatments
contraindications for the use of auriculotherapy: scheduled Magnetic resonance imaging examination declared pregnancy, breastfeeding, artificial heart valves, Haemophilia, effective anticoagulation treatment
having received auriculotherapy treatment in the indication of the study in the last 12 months before inclusion
scheduled to start a new drug or non-drug therapy which could interfere with the study: antidepressant, opioids, anticonvulsant psychological therapy, , physiotherapy, deep brain stimulation, etc..)
modification of prophylactic treatment during the month before inclusion